Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Parish, Lawrence Charles
Crissey, John Thome
and
Parish, Jennifer L.
1991.
Bibliography of Secondary Sources on the History of Dermatology.
International Journal of Dermatology,
Vol. 30,
Issue. 7,
p.
509.
Luttenberger, Franz
1992.
Arrhenius vs. Ehrlich on immunochemistry: Decisions about scientific progress in the context of the Nobel prize.
Theoretical Medicine,
Vol. 13,
Issue. 2,
p.
137.
Marsch, Ulrich
1994.
Strategies for success: Research organization in German chemical companies and IG Farben until 1936*.
History and Technology,
Vol. 12,
Issue. 1,
p.
23.
Vernon, Keith
1994.
Microbes at work. Micro-organisms, the D.S.I.R. and industry in Britain, 1900–1936.
Annals of Science,
Vol. 51,
Issue. 6,
p.
593.
Löwy, Ilana
1994.
On hybridizations, networks and new disciplines: The Pasteur Institute and the development of microbiology in France.
Studies in History and Philosophy of Science Part A,
Vol. 25,
Issue. 5,
p.
655.
Kasten, Frederick H.
1996.
Paul Ehrlich: Pathfinder in Cell Biology 1. Chronicle of His Life and Accomplishments in Immunology, Cancer Research, and Chemotherapy1: Paul Ehrlich's Recipe for Success: “Patience, Ability, Money and Luck”.
Biotechnic & Histochemistry,
Vol. 71,
Issue. 1,
p.
2.
Cassier, Maurice
2002.
Les logiques de l'innovation.
p.
155.
Mahmoudian, Masoud
and
Rahimi-Moghaddam, Parvaneh
2008.
The life and work of Abu ul-Ala Shirazi (d. 1001): a Persian pioneer in the treatment of malaria, in the style of Rhazes (865–925).
Journal of Medical Biography,
Vol. 16,
Issue. 4,
p.
186.
Hüntelmann, Axel C.
2008.
The Dynamics ofWertbestimmung.
Science in Context,
Vol. 21,
Issue. 2,
p.
229.
Rommetveit, Kjetil
2008.
Towards a hermeneutic of technomedical objects.
Theoretical Medicine and Bioethics,
Vol. 29,
Issue. 2,
p.
103.
Gradmann, Christoph
2008.
Locating Therapeutic Vaccines in Nineteenth-Century History.
Science in Context,
Vol. 21,
Issue. 2,
p.
145.
Prüll, Cay-Rüdiger
2010.
Evaluating and Standardizing Therapeutic Agents, 1890–1950.
p.
13.
Grabenstein, John D.
2010.
Vaccines: A Biography.
p.
105.
Tilles, Gérard
2011.
Dermatologie des XIXe et XXe siècles Mutations et controverses.
p.
183.
Liebenau, Jonathan
and
Gundlach, Justin
2013.
Modernizing the Business of Health: Pharmaceuticals in Britain, in comparison with Germany and the United States, 1890–1940: Table 1.
Industrial and Corporate Change,
Vol. 22,
Issue. 3,
p.
807.
Buchwalow, Igor
Boecker, Werner
and
Tiemann, Markus
2015.
The contribution of Paul Ehrlich to histochemistry: a tribute on the occasion of the centenary of his death.
Virchows Archiv,
Vol. 466,
Issue. 1,
p.
111.
2015.
L'invention d'un médicament.
p.
237.
Andrade, E.L.
Bento, A.F.
Cavalli, J.
Oliveira, S.K.
Freitas, C.S.
Marcon, R.
Schwanke, R.C.
Siqueira, J.M.
and
Calixto, J.B.
2016.
Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies.
Brazilian Journal of Medical and Biological Research,
Vol. 49,
Issue. 11,
Campbell, J. N.
and
Rooney, Steven M.
2018.
A Time-Release History of the Opioid Epidemic.
p.
59.
Sawchik, J.
Hamdani, J.
and
Vanhaeverbeek, M.
2018.
Randomized clinical trials and observational studies in the assessment of drug safety.
Revue d'Épidémiologie et de Santé Publique,
Vol. 66,
Issue. 3,
p.
217.